Project 3: Human Fetal Lung, Arsenic Exposure, Tissue Remodeling

项目 3:人类胎儿肺、砷暴露、组织重塑

基本信息

  • 批准号:
    7846632
  • 负责人:
  • 金额:
    $ 6.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-02-15 至 2012-11-30
  • 项目状态:
    已结题

项目摘要

Fetal lung development requires coordinated remodeling of pulmonary epithelium, vasculature and supporting matrix to establish an effective gas exchange system. Intrauterine and early postnatal exposure to environmental toxicants may disrupt this delicate balance and result in respiratory morbidity in children and adults. Inorganic arsenic is a ubiquitous environmental toxicant that targets the lung with both neoplasfic and non-neoplasfic endpoints. Recent evidence in mice suggests that gestafional exposure to arsenic disrupts fetal lung development and results in an asthma-like phenotype in the offspring. Studies in humans described increased incidence of bronchiectasis, dyspnea, chronic obstructive and restrictive lung disease in children and young adults exposed to arsenic in utem. This pilot project will develop and employ a human fetal lung xenograft model to determine the mechanisms of arsenic-induced disruption of human fetal lung remodeling. Our central hypothesis is: Arsenic exposure of human fetal lunq xenotransplants results in disrupted postglandular lung remodeling, mediated by molecular and epigenetic alterations. We will perform xenotransplants of 2nd trimester human fetal lungs, allowing study of human lung maturation and cytodifferentiation from pseudoglandular and canalicular stages of development. Jn Specific Aim 1. we will develop a human fetal lung xenograft model of in utero arsenic exposure. We will assess the best graft conditions, including size, site and initial stage to ensure opfimal graft survival and maturation. In addifion. we will study the pharmacokinetic relationship between arsenic exposure in the drinking water and fissue-specific distribution of arsenic and its metabolites. In Specific Aim 2. we will determine the effects of environmentally relevant levels of arsenic exposure on growth kinefics. cytodifferentiation and global gene expression in the developing human lung. Finally, in Specific Aim 3. we will determine the epigenetic modifications induced by arsenic exposure in the human xenografts. This pilot project will lead to the elucidation of molecular targets and biomaricers of inorganic arsenic exposure during lung development and may give insight into the efiology of arsenic-induced respiratory disease and lung cancers.
胎儿肺发育需要肺上皮、脉管系统和肺组织的协调重塑 支持矩阵建立有效的气体交换系统。宫内和产后早期 接触环境毒物可能会破坏这种微妙的平衡并导致呼吸道疾病 在儿童和成人中。无机砷是一种普遍存在的环境毒物,它的目标是肺部 肿瘤和非肿瘤终点。最近在小鼠身上的证据表明,妊娠期 接触砷会扰乱胎儿肺部发育,导致胎儿出现类似哮喘的表型 后代。对人类的研究表明,支气管扩张、呼吸困难、慢性 子宫内暴露于砷的儿童和年轻人的阻塞性和限制性肺病。这 试点项目将开发并采用人胎肺异种移植模型来确定其机制 砷引起的人胎肺重塑破坏。我们的中心假设是:砷 人类胎儿 lunq 异种移植物的暴露会导致腺后肺重塑破坏, 由分子和表观遗传改变介导。我们将进行第二个三个月的异种移植 人胎肺,可以研究人肺的成熟和假腺体的细胞分化 和小管的发育阶段。 Jn 具体目标 1. 我们将开发人胎肺异种移植物 子宫内砷暴露模型。我们将评估最佳移植条件,包括大小、部位和 初始阶段,以确保最佳移植物存活和成熟。另外。我们将研究 饮用水中砷暴露与组织特异性之间的药代动力学关系 砷及其代谢物的分布在具体目标 2 中,我们将确定以下效果: 环境相关的砷暴露水平对生长动力学的影响。细胞分化和全局 发育中的人肺中的基因表达。最后,在具体目标 3 中,我们将确定 人类异种移植物中砷暴露引起的表观遗传修饰。该试点项目将引领 阐明肺期间无机砷暴露的分子靶标和生物标志物 发展并可能有助于深入了解砷引起的呼吸道疾病和肺部疾病的病因学 癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MONIQUE E DEPAEPE其他文献

MONIQUE E DEPAEPE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MONIQUE E DEPAEPE', 18)}}的其他基金

COBRE: W & I HOSP OF RI: FAS-MEDIATED APOPTOSIS IN PERINATAL LUNG REMODELING
铜芯:W
  • 批准号:
    7720724
  • 财政年份:
    2008
  • 资助金额:
    $ 6.1万
  • 项目类别:
COBRE: W & I HOSP OF RI: FAS-MEDIATED APOPTOSIS IN PERINATAL LUNG REMODELING
铜芯:W
  • 批准号:
    7610526
  • 财政年份:
    2007
  • 资助金额:
    $ 6.1万
  • 项目类别:
COBRE: W & I HOSP OF RI: FAS-MEDIATED APOPTOSIS IN PERINATAL LUNG REMODELING
铜芯:W
  • 批准号:
    7381993
  • 财政年份:
    2006
  • 资助金额:
    $ 6.1万
  • 项目类别:
COBRE: W & I HOSP OF RI: FAS-MEDIATED APOPTOSIS IN PERINATAL LUNG REMODELING
铜芯:W
  • 批准号:
    7171214
  • 财政年份:
    2005
  • 资助金额:
    $ 6.1万
  • 项目类别:
COBRE: W & I HOSP OF RI: FAS-MEDIATED APOPTOSIS IN PERINATAL LUNG REMODELING
铜芯:W
  • 批准号:
    6981889
  • 财政年份:
    2004
  • 资助金额:
    $ 6.1万
  • 项目类别:
Project 3: Human Fetal Lung, Arsenic Exposure, Tissue Remodeling
项目 3:人类胎儿肺、砷暴露、组织重塑
  • 批准号:
    8208763
  • 财政年份:
  • 资助金额:
    $ 6.1万
  • 项目类别:
Project 3: Human Fetal Lung, Arsenic Exposure, Tissue Remodeling
项目 3:人类胎儿肺、砷暴露、组织重塑
  • 批准号:
    8375006
  • 财政年份:
  • 资助金额:
    $ 6.1万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 6.1万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 6.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 6.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 6.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 6.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 6.1万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 6.1万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 6.1万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 6.1万
  • 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
  • 批准号:
    2706416
  • 财政年份:
    2022
  • 资助金额:
    $ 6.1万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了